Wird geladen...
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
INTRODUCTION: Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited. OBJECTIVE: To assess the effectiveness and safety...
Gespeichert in:
| Veröffentlicht in: | Front Immunol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5827539/ https://ncbi.nlm.nih.gov/pubmed/29520266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00248 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|